OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BCAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioAtla (BCAB) Earnings Date & Reports

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCAB is expected to report earnings to fall 14.59% to -27 cents per share on November 05

Q3'25

Est.

$-0.27

Q2'25

Missed

by $0.06

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.19

The last earnings report on August 07 showed earnings per share of -31 cents, missing the estimate of -25 cents. With 1.64M shares outstanding, the current market capitalization sits at 23.88M.

View a ticker or compare two or three

Compare

BCAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BCAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BCAB showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11085 Torreyana Road

Phone

+1 858 558-0708

Employees

Web

https://www.bioatla.com